RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IMVT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Immunovant, Inc. stock price up 3.94% on Wednesday
(Updated on May 01, 2024)

Sell candidate since Apr 16, 2024 Loss -6.18% PDF

The Immunovant, Inc. stock price gained 3.94% on the last trading day (Wednesday, 1st May 2024), rising from $27.44 to $28.52. During the last trading day the stock fluctuated 7.18% from a day low at $27.30 to a day high of $29.26. The price has fallen in 6 of the last 10 days but is still up by 0.32% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 133 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $36.64 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -24.40% during the next 3 months and, with a 90% probability hold a price between $20.17 and $23.42 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IMVT Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, April 26, 2024, and so far it has risen 4.97%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Immunovant, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $30.22. On a fall, the stock will find some support from the short-term average at $27.97. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Immunovant, Inc. stock

Immunovant, Inc. finds support from accumulated volume at $28.43 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.96 between high and low, or 7.18%. For the last week, the stock has had daily average volatility of 4.90%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IMVT) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect Immunovant, Inc. to open at $28.36, and during the day (based on 14 day Average True Range), to move between $27.09 and $29.95, which gives a possible trading interval of +/-$1.43 (+/-5.01%) up or down from last closing price. If Immunovant, Inc. takes out the full calculated possible swing range there will be an estimated 10.03% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $28.43 (0.32%) than the resistance at $31.69 (11.12%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Immunovant, Inc. stock A Buy?

Immunovant, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.016 Sell Candidate Unchanged

Predicted Opening Price for Immunovant, Inc. of Thursday, May 2, 2024

Fair opening price May 2, 2024 Current price
$28.36 ( 0.561%) $28.52

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IMVT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 30.32 6.31 %
R2 29.57 3.69 %
R1 29.11 2.06 %
Current price: 28.52
Support S1 27.61 -3.19 %
S2 27.15 -4.81 %
S3 26.40 -7.43 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 33.09 16.02 %
R2 33.06 15.92 %
R1 31.69 11.12 %
Current price 28.52
Support S1 28.43 -0.316%
S2 27.49 -3.61%
S3 27.17 -4.73%

FAQ

What is the symbol for Immunovant, Inc. Stock and on which exchange is it traded?
The symbol for Immunovant, Inc. is IMVT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Immunovant, Inc. Stock?
Immunovant, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Immunovant, Inc. Stock?
Immunovant, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Immunovant, Inc. Stock.

What's the current price of Immunovant, Inc. Stock?
As of the end of day on the May 01, 2024, the price of an Immunovant, Inc. (IMVT) share was $28.52.

What is the 52-week high and low for Immunovant, Inc. Stock?
The 52-week high for Immunovant, Inc. Stock is $45.58 and the 52-week low is $17.53.

What is the market capitalization of Immunovant, Inc. Stock?
As of the May 01, 2024, the market capitalization of Immunovant, Inc. is 4.144B.

When is the next earnings date for Immunovant, Inc.?
The upcoming earnings date for Immunovant, Inc. is May 27, 2024.
Click to get the best stock tips daily for free!

About Immunovant, Inc.

Immunovant. Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for... IMVT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT